Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

05.03.19	Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference (Businesswire)
05.03.19	Pfizer Prices $5,000,000,000 Debt Offering (Businesswire)
01.03.19	Pfizer: CHMP Adopts Positive Opinion For LORVIQUA - Quick Facts (RTTNews)
01.03.19	Pfizer Receives Positive CHMP Opinion for LORVIQUA® (lorlatinib) for Certain Adult Patients with Previously-Treated ALK-Positive Advanced Non-Small Cell Lung Cancer (Businesswire)
28.02.19	Pfizer Announces Serotypes Included in 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older (Businesswire)
27.02.19	Biotech Stocks Facing FDA Decision In March (RTTNews)
26.02.19	Higher Dose Of Xeljanz Tied To Blood Clots In Lungs, Death In RA Patients (RTTNews)
19.02.19	Ochsner Health System and Pfizer Partner to Develop Innovative Models for Clinical Trials (Businesswire)
19.02.19	Pfizer Receives European Approval for ZIRABEV™ (bevacizumab), a Biosimilar to Avastin®* (Businesswire)
19.02.19	Gliknik To Receive $15 Mln Payment From Pfizer On Progress With PF-06755347 (RTTNews)
19.02.19	Eli Lilly: Tanezumab 10 Mg Meets Primary Endpoint In Phase 3 Study - Quick Facts (RTTNews)
12.02.19	Merck KGaA And Pfizer : FDA Accepts For Priority Review SBLA For BAVENCIO (RTTNews)
11.02.19	Pfizer: XTANDI Plus Androgen Deprivation Therapy Meets Endpoint In ARCHES Trial (RTTNews)
11.02.19	Phase 3 ARCHES Trial Shows XTANDI® (enzalutamide) Significantly Improved Radiographic Progression-Free Survival in Men with Metastatic Hormone-Sensitive Prostate Cancer (Businesswire)
01.02.19	Pfizer Gets Positive CHMP Opinion For Vizimpro 45 Mg (RTTNews)
29.01.19	Pfizer Q4 Results Beat View; But FY19 Outlook Disappoints (RTTNews)
29.01.19	Pfizer Inc. Q4 adjusted earnings Beat Estimates (RTTNews)
29.01.19	PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2018 RESULTS (Businesswire)
29.01.19	Pfizer, Lilly Announce Results From Phase 3 Study Of Tanezumab In OA Pain (RTTNews)
29.01.19	Pfizer and Lilly Announce Top-Line Results From Second Phase 3 Study of Tanezumab in Osteoarthritis Pain (Businesswire)
15.01.19	First Device For Congenital Heart Defect, AIMT & US Shutdown, ASLN On Watch (RTTNews)
14.01.19	Pfizer Says FDA Accepts Regulatory Submissions For Review Of Tafamidis (RTTNews)
14.01.19	US FDA Accepts Regulatory Submissions for Review of Tafamidis to Treat Transthyretin Amyloid Cardiomyopathy (Businesswire)
07.01.19	Pfizer To Use CytoReason's Machine Learning Model For Drug Discovery (RTTNews)
03.01.19	Pfizer Initiates Phase 2b/3 Clinical Trial for PF-06651600, an Oral JAK3 Inhibitor, for the Treatment of Patients with Moderate to Severe Alopecia Areata (Businesswire)
31.12.18	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
27.12.18	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
22.12.18	Merck KGaA & Pfizer Decide To Discontinue JAVELIN Ovarian 100 Study Of Avelumab (RTTNews)
21.12.18	Pfizer Discontinues Phase 2b STRIVE Clinical Trial Due To Futility (RTTNews)
20.12.18	Independent Data Monitoring Committee Recommends Discontinuation of the Phase 2b STRIVE Clinical Trial of Staphylococcus aureus Vaccine Following Planned Interim Analysis (Businesswire)
20.12.18	Astellas and Pfizer Announce Positive Top-Line Results from Phase 3 ARCHES Trial of XTANDI® (enzalutamide) in Men with Metastatic Hormone-Sensitive Prostate Cancer (Businesswire)
19.12.18	GSK, Pfizer To Combine Consumer Health Businesses Into New JV - Quick Facts (RTTNews)
19.12.18	Pfizer and GlaxoSmithKline Announce Joint Venture to Create a Premier Global Consumer Healthcare Company (Businesswire)
18.12.18	Pfizer Invites Public to View and Listen to Webcast of January 29 Conference Call with Analysts (Businesswire)
14.12.18	Pfizer Declares First-Quarter 2019 Dividend (Businesswire)
14.12.18	Pfizer Receives Positive CHMP Opinion for Oncology Biosimilar, ZIRABEV™ (bevacizumab) (Businesswire)
14.12.18	Pfizer Initiates Phase3 Program For 20-Valent Pneumococcal Conjugate Vaccine (RTTNews)
14.12.18	Pfizer Initiates Phase 3 Program for 20-Valent Pneumococcal Conjugate Vaccine for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older (Businesswire)
11.12.18	Pfizer Posting Notable Loss After Downgrade By J.P. Morgan (RTTNews)
03.12.18	Pfizer Presents Positive Data For PF-05280586, Potential Biosimilar To Rituximab (RTTNews)
02.12.18	Pfizer Presents Positive 26-Week Data For PF-05280586, A Potential Biosimilar To Rituximab, At The American Society Of Hematology Annual Meeting (Businesswire)
30.11.18	Pfizer Reaches Global Agreement With AbbVie; To Withdraw Pending Litigation (RTTNews)
30.11.18	Pfizer Reaches a Global Agreement with AbbVie (Businesswire)
27.11.18	Pfizer Receives Six Months Pediatric Exclusivity for LYRICA® (pregabalin) (Businesswire)
21.11.18	U.S. FDA Approves DAURISMO™ (glasdegib) for Adult Patients with Newly-Diagnosed Acute Myeloid Leukemia (AML) for Whom Intensive Chemotherapy is Not an Option (Businesswire)
21.11.18	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
19.11.18	Merck KGaA, Pfizer: JAVELIN Ovarian 200 Trial Did Not Meet Primary Endpoints (RTTNews)
18.11.18	Pfizer Plans To Raise Prices On 41 Drugs In January, Despite Pressure From Trump (RTTNews)
06.11.18	Nektar Therapeutics And Pfizer Enter Into New Clinical Oncology Collaboration (RTTNews)
02.11.18	U.S. FDA Approves LORBRENA® (lorlatinib) for Previously-Treated ALK-Positive Metastatic NSCLC (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

20:03		Freundlicher Handel in New York: Dow Jones präsentiert sich am Freitagnachmittag fester
18:01		Börse New York in Grün: Dow Jones bewegt sich am Mittag im Plus
17:58		Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen
17:58		Handel in Frankfurt: TecDAX letztendlich in Grün
17:58		Freundlicher Handel: Börsianer lassen SPI schlussendlich steigen
17:58		Gewinne in Frankfurt: SDAX zum Handelsende freundlich
17:58		Zuversicht in London: FTSE 100 beendet die Freitagssitzung in der Gewinnzone

20:03

Freundlicher Handel in New York: Dow Jones präsentiert sich am Freitagnachmittag fester

18:01

Börse New York in Grün: Dow Jones bewegt sich am Mittag im Plus

17:58

Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen

17:58

Handel in Frankfurt: TecDAX letztendlich in Grün

17:58

Freundlicher Handel: Börsianer lassen SPI schlussendlich steigen

17:58

Gewinne in Frankfurt: SDAX zum Handelsende freundlich